Familial risks of congenital heart defect assessed in a population-based epidemiologic study
β Scribed by Boughman, Joann A. ;Berg, Kate A. ;Astemborski, Jacqueline A. ;Clark, Edward B. ;McCarter, Robert J. ;Rubin, Judith D. ;Ferencz, Charlotte ;Opitz, John M. ;Reynolds, James F.
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- English
- Weight
- 701 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0148-7299
No coin nor oath required. For personal study only.
β¦ Synopsis
Congenital heart defects (CHD) represent a heterogeneous group of disorders caused by chromosome abnormalities, mendelian disorders, teratogenic exposures, and unknown etiologic mechanisms. A large group of various isolated defects is presumably multifactorial in origin. Previous studies of familial risks for specific anatomic defects obtained from clinical series may include significant biases and obscured pathogenic relationships. In this population-based study we analyzed all cases of CHD in infants and a control birth cohort in the Baltimore-Washington area. The rates of CHD were defined for first-degree relatives of cases with isolated defects, grouped by a pathogenic classification scheme. Precurrence risks were found to vary among the groups, and risks for flow lesions were higher than previously reported. The sibling precurrence risk for hypoplastic left heart syndrome (13.5 %) was not significantly different from that expected for an autosomal recessive mechanism; the risks for different types of ventricular septa1 defects (VSD) varied among mechanistic groups. The results indicate that the additive multifactorial model does not adequately account for the risks in all forms of isolated CHD of unknown etiology.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND: There is a need for caseβcontrol studies of the effect of paroxetine on the occurrence of specific heart defects. ## METHODS: We performed a caseβcontrol study with data from a populationβbased birth defects registry in the Netherlands. All the children born between 19
## Abstract During the period 1981β1986, 1605 infants presenting a major congenital heart defect (CHD) were identified in Sweden. Using the personal identification numbers of the mothers, 1507 of them could be linked to the Medical Birth Registry and two controls were selected for each infant. For